Cyclic beta-ketoamide ACAT inhibitors

Details Cyclic beta-ketoamide ACAT inhibitors Cyclic beta-ketoamide ACAT inhibitors

1991-03-06

1992-06-02

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546256, 546265, 546331, 546333, 546335, 546337, 548510, 560 12, 562426, 562435, 562440, 564 74, 564163, 564167, 564171, 564181, 564184, 564185, A61K 3144, C07D21350

Patent

active

051186977

ABSTRACT:
Novel cyclic beta-ketoamides which contain an aryl moiety having utility as blood cholesterol lowering agents rendering them useful in the treatment of atherosclerosis.

REFERENCES:
patent: 3510492 (1970-05-01), Semuszkovicz et al.
patent: 3600360 (1971-08-01), Bukac et al.
patent: 4075217 (1978-02-01), Gelotte et al.
patent: 4454324 (1984-07-01), Madding et al.
Jager, Chem. Ber. 105, 1972, pp. 137-149.
Chem. Abstract 76:99585y, Chem. Ber. 1972, 105(1), 137-49.
Chem. Abstract 77:101362q, J. Chem. Soc., Perkin Trans. 1, 1972, (17), 2119-21.

Affiliated with

Also associated with

Rating

Cyclic beta-ketoamide ACAT inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic beta-ketoamide ACAT inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic beta-ketoamide ACAT inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2228700